Alpha 2.0
Login Register
» Authors » C M Deroose

C M Deroose

Explore the profile of C M Deroose including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 126
Followers 0
Related Specialties
Radiology
Gastroenterology
Cardiology & Vascular Diseases
Top 10 Co-Authors
O Gheysens
P Flamen
C Verslype
C L Stothers
D B Brown
S C Kappadath
R A J O Dierckx
A J A T Braat
A W J M Glaudemans
A Frilling
Published In
Acta Gastroenterol Belg
Cardiovasc Intervent Radiol
Eur J Nucl Med Mol Imaging
Strahlenther Onkol
Gynecol Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Successful reversal of intestinal obstruction by PRRT: two case reports and literature review of PRRT in Small Intestinal Neuroendocrine Tumors with mesenteric fibrosis
Dubois E, Geelen R, Leupe H, Deroose C, Verslype C
Acta Gastroenterol Belg . 2025 Jan; 87(4):517-520. PMID: 39745038
Small intestinal neuroendocrine tumors (SI-NETs) typically follow an indolent disease course and are often accompanied by mesenteric lymph node metastases upon diagnosis. These tumors can incite a fibroblastic reaction within...
2.
Fulminant ectopic Cushing's syndrome caused by metastatic small intestine neuroendocrine tumour - a case report and review of the literature
Alliet B, Severi C, Veekmans T, Cuypers J, Topal H, Deroose C, et al.
Acta Gastroenterol Belg . 2024 Mar; 87(1):48-51. PMID: 38431792
Cushing's syndrome (CS) secondary to adrenocorticotropic hormone (ACTH) producing tumours is a severe condition with a challenging diagnosis. Ectopic ACTH-secretion often involves neuroendocrine tumours (NET) in the respiratory tract. ACTH-secreting...
3.
Intra-Arterial Therapies for Liver Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
Aarts B, Munoz F, Wildiers H, Dezentje V, Baetens T, Schats W, et al.
Cardiovasc Intervent Radiol . 2021 Jul; 44(12):1868-1882. PMID: 34322751
Purpose: Performing a systematic review and meta-analysis to assess the evidence of intra-arterial therapies in liver metastatic breast cancer (LMBC) patients. Methods: A systemic literature search was performed in PubMed,...
4.
Prognostic superiority of International Prognostic Index over [F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder
de Jesus F, Dierickx D, Vergote V, Noordzij W, Dierckx R, Deroose C, et al.
EJNMMI Res . 2021 Mar; 11(1):29. PMID: 33738643
Background: Post-transplant lymphoproliferative disorders (PTLDs) are a spectrum of hematological malignancies occurring after solid organ and hematopoietic stem cell transplantation. [F]FDG PET/CT is routinely performed at PTLD diagnosis, allowing for...
5.
Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [F]FDG PET/CT
Montes de Jesus F, Vergote V, Noordzij W, Dierickx D, Dierckx R, Diepstra A, et al.
J Clin Med . 2021 Jan; 10(2). PMID: 33477971
Post-transplant lymphoproliferative disorder (PTLD) is a complication of organ transplantation classified according to the WHO as nondestructive, polymorphic, monomorphic, and classic Hodgkin Lymphoma subtypes. In this retrospective study, we investigated...
6.
Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method
Cuyle P, Geboes K, Carton S, Casneuf V, Decaestecker J, De Man M, et al.
Acta Gastroenterol Belg . 2020 Dec; 83(4):643-653. PMID: 33321023
Background And Study Aims: Neuroendocrine neoplasms (NENs) are relatively rare, with marked clinical and biological heterogeneity. Consequently, many controversial areas remain in diagnosis and optimal treatment stratification for NEN patients....
7.
Disseminated histoplasmosis in a kidney liver transplant patient from a non-endemic area: A diagnostic challenge
Carmans L, Van Craenenbroeck A, Lagrou K, Deroose C, Sagaert X, Wolthuis A, et al.
IDCases . 2020 Oct; 22:e00971. PMID: 33088713
Disseminated histoplasmosis is a rare opportunistic infection in non-endemic areas, where the disease is often diagnosed late. The spectrum of clinical manifestations is broad and life-threatening complications occur. We present...
8.
Radioembolization with Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy
Braat A, Ahmadzadehfar H, Kappadath S, Stothers C, Frilling A, Deroose C, et al.
Cardiovasc Intervent Radiol . 2019 Oct; 43(2):246-253. PMID: 31646375
Purpose: Peptide receptor radionuclide therapy (PRRT) and radioembolization are increasingly used in neuroendocrine neoplasms patients. However, concerns have been raised on cumulative hepatotoxicity. The aim of this sub-analysis was to...
9.
Radioembolization with Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity
Braat A, Kappadath S, Ahmadzadehfar H, Stothers C, Frilling A, Deroose C, et al.
Cardiovasc Intervent Radiol . 2019 Jan; 42(3):413-425. PMID: 30603975
Purpose: Radioembolization of liver metastases of neuroendocrine neoplasms (NEN) has shown promising results; however, the current literature is of limited quality. A large international, multicentre retrospective study was designed to...
10.
Using PET for therapy monitoring in oncological clinical trials: challenges ahead
Deroose C, Stroobants S, Liu Y, Shankar L, Bourguet P
Eur J Nucl Med Mol Imaging . 2017 Apr; 44(Suppl 1):32-40. PMID: 28451825
Molecular imaging with PET has emerged as a powerful imaging tool in the clinical care of oncological patients. Assessing therapy response is a prime application of PET and so the...